Reaktion #320104

ord-d75d5ef60c054947b3ed1bdf50f8092b

Reaktionsgleichung

CCCCc1nc2c(C)cc(N3CCCCC3=O)cc2n1Cc1ccc(-c2ccccc2C#N)cc1
4'-[[2-n-butyl-4-methyl-6-(2-oxo-piperidin-1-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl
[N-]=[N+]=[N-].[Na+]
sodium azide
→
CCCCc1nc2c(C)cc(N3CCCCC3=O)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
4'-[[2-n-Butyl-4-methyl-6-(2-oxo-piperidin-1-yl)-benzimidazol1-yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl

Edukte

CCCCc1nc2c(C)cc(N3CCCCC3=O)cc2n1Cc1ccc(-c2ccccc2C#N)cc1
4'-[[2-n-butyl-4-methyl-6-(2-oxo-piperidin-1-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl
[N-]=[N+]=[N-].[Na+]
sodium azide

Reagenzien

Keine

Lösungsmittel

CN(C)C=O
dimethyl-formamide

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Vorschrift

Prepared analogously to Example 10 from 4'-[[2-n-butyl-4-methyl-6-(2-oxo-piperidin-1-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl and sodium azide in dimethyl-formamide.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05591762uspto-grants-1997_01